Miriam GAGGIANESI

Assistant Professor

University of Palermo

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Miriam Gaggianesi is an Assistant Professor at the University of Palermo, Italy. Her research focuses on the intersection of cancer biology and therapeutic strategies, with recent publications exploring innovative approaches to drug screening and targeting cancer stem cells. Key areas of interest include breast cancer, uveal melanoma, and thyroid cancer, as well as the role of the tumor microenvironment in disease progression.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (10)

Davide Cora'

Associate Professor

Università degli Studi del Piemonte Orientale

ITALY

View details

Sonia Coni

Sapienza University of Rome

ITALY

View details

Armando Genazzani

Università degli Studi del Piemonte Orientale

ITALY

View details

Maria Rita Bongiorno

Prof ordinario

Università degli Studi di Palermo

ITALY

View details

University of Catania

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miriam GAGGIANESI

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

A Novel Tumor on Chip Mimicking the Breast Cancer Microenvironment for Dynamic Drug Screening

An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma

MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation

Recapitulating thyroid cancer histotypes through engineering embryonic stem cells

Dissecting the Mechanism of Action of Spiperone—A Candidate for Drug Repurposing for Colorectal Cancer

Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy

Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy

Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells

Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51

Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

FACS-based protocol to assess cytotoxicity and clonogenic potential of colorectal cancer stem cells using a Wnt/β-catenin signaling pathway reporter

Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery

Collaborators (10)

Davide Cora'

Sonia Coni

Armando Genazzani

Maria Rita Bongiorno

Vincenzo La Carrubba

Rosario Caltabiano

Giorgio Stassi

Enrico De Smaele

simone di franco

Elisabetta Sciacca

Make your next move.

Miriam GAGGIANESI

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

A Novel Tumor on Chip Mimicking the Breast Cancer Microenvironment for Dynamic Drug Screening

An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma

MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation

Recapitulating thyroid cancer histotypes through engineering embryonic stem cells

Dissecting the Mechanism of Action of Spiperone&mdash;A Candidate for Drug Repurposing for Colorectal Cancer

Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy

Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy

Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells

Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51

Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

FACS-based protocol to assess cytotoxicity and clonogenic potential of colorectal cancer stem cells using a Wnt/β-catenin signaling pathway reporter

Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery

Collaborators (10)

Davide Cora'

Sonia Coni

Armando Genazzani

Maria Rita Bongiorno

Vincenzo La Carrubba

Rosario Caltabiano

Giorgio Stassi

Enrico De Smaele

simone di franco

Elisabetta Sciacca

Make your next move.

Dissecting the Mechanism of Action of Spiperone—A Candidate for Drug Repurposing for Colorectal Cancer